LIFELINE SPAC I OYJ A EO1 (0CD) - Total Assets
Based on the latest financial reports, LIFELINE SPAC I OYJ A EO1 (0CD) holds total assets worth €117.90 Million EUR (≈ $137.84 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See LIFELINE SPAC I OYJ A EO1 net assets for net asset value and shareholders' equity analysis.
LIFELINE SPAC I OYJ A EO1 - Total Assets Trend (2021–2025)
This chart illustrates how LIFELINE SPAC I OYJ A EO1's total assets have evolved over time, based on quarterly financial data.
LIFELINE SPAC I OYJ A EO1 - Asset Composition Analysis
Current Asset Composition (December 2025)
LIFELINE SPAC I OYJ A EO1's total assets of €117.90 Million consist of 81.8% current assets and 18.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 18.7% |
| Accounts Receivable | €1.00 Million | 0.9% |
| Inventory | €1.20 Million | 1.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €3.50 Million | 3.0% |
| Goodwill | €4.00 Million | 3.4% |
Asset Composition Trend (2021–2025)
This chart illustrates how LIFELINE SPAC I OYJ A EO1's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see LIFELINE SPAC I OYJ A EO1 (0CD) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LIFELINE SPAC I OYJ A EO1's current assets represent 81.8% of total assets in 2025, an increase from 2.2% in 2021.
- Cash Position: Cash and equivalents constituted 18.7% of total assets in 2025, up from 2.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 3.4% of total assets.
LIFELINE SPAC I OYJ A EO1 Competitors by Total Assets
Key competitors of LIFELINE SPAC I OYJ A EO1 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Givaudan SA
F:GIN1
|
Germany | €11.86 Billion |
|
EVONIK INDUST.(U.ARD)2
F:EVKA
|
Germany | €17.98 Billion |
|
Huaibei Mining Holdings Co Ltd
SHG:600985
|
China | CN¥89.26 Billion |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
China | CN¥6.07 Billion |
|
Fujian Kuncai Material Tech
SHG:603826
|
China | CN¥4.98 Billion |
|
Dalian Bio-Chem Co Ltd
SHG:603360
|
China | CN¥3.99 Billion |
|
Aarti Industries Limited
NSE:AARTIIND
|
India | Rs132.99 Billion |
|
Shenzhen Cotran New Material Co Ltd Class A
SHE:300731
|
China | CN¥1.34 Billion |
LIFELINE SPAC I OYJ A EO1 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 11.90 | 14.23 | 1.04 |
| Quick Ratio | 11.75 | 14.08 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €88.30 Million | €99.20 Million | €4.51 Million |
LIFELINE SPAC I OYJ A EO1 - Advanced Valuation Insights
This section examines the relationship between LIFELINE SPAC I OYJ A EO1's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.42 |
| Latest Market Cap to Assets Ratio | 2.22 |
| Asset Growth Rate (YoY) | -6.0% |
| Total Assets | €117.90 Million |
| Market Capitalization | $261.36 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values LIFELINE SPAC I OYJ A EO1's assets at a significant premium (2.22x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: LIFELINE SPAC I OYJ A EO1's assets decreased by 6.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for LIFELINE SPAC I OYJ A EO1 (2021–2025)
The table below shows the annual total assets of LIFELINE SPAC I OYJ A EO1 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €117.90 Million ≈ $137.84 Million |
-5.98% |
| 2024-12-31 | €125.40 Million ≈ $146.61 Million |
+20.58% |
| 2023-12-31 | €104.00 Million ≈ $121.59 Million |
+2.27% |
| 2022-12-31 | €101.70 Million ≈ $118.89 Million |
-0.54% |
| 2021-12-31 | €102.25 Million ≈ $119.54 Million |
-- |
About LIFELINE SPAC I OYJ A EO1
Canatu Oyj develops and sells carbon nanotubes (CNTs) and related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries in Finland, the United States, Japan, and Taiwan. The company offers custom CNT synthesis reactors; CNT membrane for high-power EUV lithography and X-Ray filter applications; EUV pellicies to protect photomask for contaminati… Read more